I agree that this site is using cookies. You can find further informations here.
X
Muus, Petra
106  results:
Search for persons X
?
1

Real‐world experience of pegcetacoplan in paroxysmal noctur..:

Griffin, Morag ; Kelly, Richard ; Brindel, Isabelle...
American Journal of Hematology.  99 (2024)  5 - p. 816-823 , 2024
Link: https://doi.org/10.1002/..
 
?
2

P797: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND..:

Kelly, Richard ; Houghton, Nicola ; Munir, Talha...
HemaSphere.  7 (2023)  S3 - p. e6873083 , 2023
Link: https://doi.org/10.1097/..
 
?
3

Phase II trials of zilucoplan in paroxysmal nocturnal hemog..:

Kulasekararaj, Austin G. ; Lehtinen, Anna-Elina ; Forsyth, Cecily...
Haematologica.  109 (2023)  3 - p. 929-935 , 2023
Link: https://doi.org/10.3324/..
 
?
4

18 A phase 2, open-label study evaluating the safety and ef..:

Kelly, Richard J. ; Houghton, Nicola ; Munir, Talha...
Immunobiology.  228 (2023)  5 - p. 152476 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Clinical and prognostic significance of small paroxysmal no..:

Fattizzo, Bruno ; Ireland, Robin ; Dunlop, Alan...
Leukemia.  35 (2021)  11 - p. 3223-3231 , 2021
Link: https://doi.org/10.1038/..
 
?
6

A phase I clinical trial to study the safety of treatment w..:

Muus, Petra ; Langemeijer, Saskia ; van Bijnen, Sandra..
Leukemia Research.  105 (2021)  - p. 106573 , 2021
Link: https://doi.org/10.1016/..
 
?
7

The incidence and prevalence of patients with paroxysmal no..:

Richards, Stephen J. ; Painter, Daniel ; Dickinson, Anita J....
European Journal of Haematology.  107 (2021)  2 - p. 211-218 , 2021
Link: https://doi.org/10.1111/..
 
?
8

Survival Improvement over Time of 960 s-AML Patients Includ..:

Ramadan, Safaa M. ; Suciu, Stefan ; Stevens-Kroef, Marian J. P. L....
Cancers.  12 (2020)  11 - p. 3334 , 2020
Link: https://doi.org/10.3390/..
 
?
9

COVID‐19 infection in patients on anti‐complement therapy: ..:

Pike, Alexandra ; Muus, Petra ; Munir, Tahla...
British Journal of Haematology.  191 (2020)  1 - p. , 2020
Link: https://doi.org/10.1111/..
 
?
10

Impact of the type of anthracycline and of stem cell transp..:

Baron, Frédéric ; Efficace, Fabio ; Cannella, Laura...
American Journal of Hematology.  95 (2020)  7 - p. 749-758 , 2020
Link: https://doi.org/10.1002/..
 
?
11

Successful treatment of a PNH patient non‐responsive to ecu..:

Schols, Saskia ; Nunn, Miles A. ; Mackie, Ian...
British Journal of Haematology.  188 (2019)  2 - p. 334-337 , 2019
Link: https://doi.org/10.1111/..
 
?
12

Similar outcomes of alemtuzumab-based hematopoietic cell tr..:

Sheth, Vipul Sharad ; Potter, Victoria ; Gandhi, Shreyans A....
Blood Advances.  3 (2019)  20 - p. 3070-3079 , 2019
Link: https://doi.org/10.1182/..
 
?
13

Cytogenetic clonal heterogeneity is not an independent prog..:

Baron, Frédéric ; Stevens-Kroef, Marian ; Kicinski, Michal...
Annals of Hematology.  97 (2018)  10 - p. 1785-1795 , 2018
Link: https://doi.org/10.1007/..
 
?
14

Romiplostim monotherapy in thrombocytopenic patients with m..:

Fenaux, Pierre ; Muus, Petra ; Kantarjian, Hagop...
British Journal of Haematology.  178 (2017)  6 - p. 906-913 , 2017
Link: https://doi.org/10.1111/..
 
?
15

Clinical characteristics and outcomes according to age in l..:

Fenaux, Pierre ; Giagounidis, Aristoteles ; Selleslag, Dominik...
Journal of Hematology & Oncology.  10 (2017)  1 - p. , 2017
Link: https://doi.org/10.1186/..
 
1-15